It has been proposed that glucagon hypersecretion in the presence of high glucose concentrations, as in T2DM, may be associated with a lower inhibitory effect of insulin on α-cells [32], impaired glucose sensing by α-cells or malfunction of neural regulation [17] rather than augmented α-cell expansion [16]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.